Due to the worldwide outbreak of coronavirus (COVID-19), the 2020 Progenitor Cell Translational Consortium (PCTC) Cardiovascular Bioengineering (CVBE) Symposium will be held in a virtual format on December 5, 2020.
The event was originally scheduled for the spring in Göttingen, Germany and was expected to draw speakers and guests from all over the world. This international collaboration is co-hosted and co-organized by UAB BME Chair Jay Zhang, M.D., Ph.D., and Wolfram Zimmerman, Ph.D., of the University Medical Center Göttingen.
The symposium provides a forum for trainees and junior investigators to present their work in the areas of gene editing, induced pluripotent stem cells, and cardiac stem cells in the context of heart failure, as well as general topics in cardiovascular bioengineering.
Additional topics will include vascular tissue engineering, cardiac development, exosomes, microRNAs, and mitochondria. Cardiac gene and cardiac cell therapy will be center stage.
Videos from the 2019 symposium presentations may be viewed on YouTube. Some presentations are excluded at the presenters' request.